Spinraza 12 mg in 5 mL Injection
RxNorm 1863565
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1863565 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Spinraza 12 mg in 5 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
5 mL nusinersen 2.4 mg/ML Injection [Spinraza]
(Atom ID: 8709816)
SYPrescribable
Synonym (SY):
5 mL Spinraza 2.4 mg/ML Injection
(Atom ID: 8709818)
PSNPrescribable
Prescribable Name (PSN):
Spinraza 12 mg in 5 mL Injection
(Atom ID: 8709817)
SYPrescribable
Synonym (SY):
Spinraza 12 mg per 5 mL Injection
(Atom ID: 8709819)
Patient Education
Nusinersen Injection
Nusinersen injection is used for the treatment of spinal muscular atrophy (an inherited condition that reduces muscle strength and movement) in infants, children, and adults. Nusinersen injection is in a class of medications called antisense oligonucleotide inhibitors. It works by increasing the amount of a certain protein necessary for the muscles and nerves to work normally.
[Learn More]
* Please review the disclaimer below.